Docosahexanoic acid (22:6, n-3) but not eicosapentaenoic acid (20:5, n-3) can induce neutrophil-mediated injury of cultured endothelial cells: involvement of neutrophil elastase

J Leukoc Biol. 1993 Dec;54(6):590-8. doi: 10.1002/jlb.54.6.590.

Abstract

Previously published work has indicated that polyunsaturated fatty acids (PUFA) may enhance neutrophil-mediated damage to host tissues. We have found that endothelial detachment was significantly increased by neutrophils pretreated with docosahexaenoic (22:6, n-3) and arachidonic (20:4, n-6) acids at 10-40 microM but not by eicosapentaenoic acid (20:5, n-3). Endothelial cell lysis as measured by 51Cr release was unaffected. The extent of detachment was dependent on both fatty acid and neutrophil pretreatment concentrations. A specific leukocyte elastase inhibitor abrogated the increased detachment but catalase had no effect. Measurement of prostaglandin I2 synthesis as an alternative nonlytic assay of endothelial function indicated that 20:4 but not 20:5 was able to stimulate neutrophil-induced endothelial PGI2 synthesis. Although all three PUFA (3-33 microM) were found to stimulate release from neutrophil-specific granules, only 22:6 and 20:4 could stimulate release of the azurophilic granules containing elastase to any significant extent. Saturated fatty acids (20:0 and 22:0) and the methyl ester of 22:6 did not cause either neutrophil-mediated endothelial detachment or degranulation. We conclude that neutrophils pretreated with 22:6 or 20:4 but not 20:5 can decrease endothelial integrity through detachment involving neutrophil elastase. These findings may have important implications for the dietary use of fish oils rich in n-3 fatty acids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology
  • Catalase / pharmacology
  • Cell Degranulation / drug effects
  • Cyclooxygenase Inhibitors / pharmacology
  • Cytochalasin B / pharmacology
  • Docosahexaenoic Acids / pharmacology*
  • Eicosapentaenoic Acid / pharmacology*
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • Epoprostenol / biosynthesis
  • Fatty Acids / pharmacology
  • Humans
  • Leukocyte Count / drug effects
  • Lipoxygenase Inhibitors / pharmacology
  • Neutrophils / cytology
  • Neutrophils / enzymology*
  • Neutrophils / physiology
  • Pancreatic Elastase / antagonists & inhibitors
  • Pancreatic Elastase / physiology*
  • Time Factors
  • Umbilical Veins / cytology

Substances

  • Amino Acid Chloromethyl Ketones
  • Cyclooxygenase Inhibitors
  • Fatty Acids
  • Lipoxygenase Inhibitors
  • Docosahexaenoic Acids
  • methyl docosahexaenoate
  • Cytochalasin B
  • methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone
  • Eicosapentaenoic Acid
  • Epoprostenol
  • Catalase
  • Pancreatic Elastase